News

Length of cancer trials has more than halved over past 30 years

BMJ 2005; 330 doi: https://doi.org/10.1136/bmj.330.7493.689 (Published 24 March 2005) Cite this as: BMJ 2005;330:689
  1. Roger Dobson
  1. Abergavenny

    The average length of cancer trials has fallen over the last 30 years from seven to three years, a new research report has shown (British Journal of Cancer 2005;92: 811-4

    The analysis shows that the median duration of trials that recruited at least 90% of the target number of participants fell from 7.2 years during the period 1971-5 to 2.7 years in the period 1996-2000.

    The study's authors, from the UK Medical Research Council's Clinical Trials Unit, used the national register of cancer trials (NRCT) of the …

    View Full Text

    Sign in

    Log in through your institution

    Free trial

    Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
    Sign up for a free trial

    Subscribe